COMP <GO>
GHC vs CVSA // EV/EBITDA & P/E VALUATION
Graham Holdings Company (NYSE) VS. Covista Inc. (NYSE) • 15-METRIC TALLY: GHC 2
— CVSA 10
▲ EV/EBITDA & P/E VALUATION LEADER: CVSA
LAST: $1,168.51 (+0.56%) • MKT CAP: $4.87B
valuation
18.1x
LAST: $124.33 (-3.44%) • MKT CAP: $4.13B
valuation
12.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GHC VS. CVSA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GHC | CVSA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 56.90% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.50% | 14.80% | -11.30 | CVSA | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 18.1x | 12.5x | +5.60 | CVSA | /valuation <GO> |
| Free Cash Flow Yield | 5.59% | 6.60% | -1.01 | CVSA | /fcf-yield <GO> |
| Operating Margin | 4.80% | 19.10% | -14.30 | CVSA | /operating-margins <GO> |
| Net Profit Margin | 6.00% | 13.30% | -7.30 | CVSA | /net-margins <GO> |
| Revenue Growth (YoY) | 2.50% | 12.90% | -10.40 | CVSA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 3.40% | -3.40 | CVSA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.05 | 4.73 | -1.68 | CVSA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | CVSA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.3 | 43.9 | +2.40 | GHC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.05 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.6x | 15.5x | +0.10 | CVSA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.87B | $4.13B | $736.6M | GHC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GHC REV | CVSA REV | GHC GROSS % | CVSA GROSS % | GHC FCF | CVSA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.91B | $1.79B | — | 56.9% | $275.3M | $287.6M |
| FY 2024 | $4.79B | $1.58B | — | 55.9% | $324.1M | $246.9M |
| FY 2023 | $4.41B | $1.45B | — | — | $259.9M | $126.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GHC // BETA —
CVSA // BETA 1.05